Clinical Chemistry Articles | Today's Clinical Lab

New Push for Routine Urine Screening at Age 3 to Detect Alport Syndrome

Kobe University

Universal early-age urinalysis may be an apt means for both better prognoses and reduced costs of medical care

Elevated levels of lipoprotein(a) are strongly linked to a higher risk of heart attack, stroke, and aortic valve disease.

Predictive Lab Test for Cardiac Events Still Rare but Increasing

University of California - San Diego

Analysis of 300 million patient records shows only 0.2 percent of the US population has been tested for lipoprotein(a)

Increased cardiometabolic testing for adults with diabetes, and all adults in the case of Lp(a), will translate to many millions of additional laboratory tests across the US in the coming years.

Trends in Cardiometabolic Testing: Lipoprotein(a) and Natriuretic Peptide Testing

Alex Fohl, PharmD

Fully automated platforms and diagnostics partnerships are essential for clinical labs to manage increasing cardiometabolic test volumes

Emerging Technologies Guide: Fall 2025

Today's Clinical Lab

Recent new and emerging technologies in the field of laboratory medicine from the 2025 September Pathogen Detection & Infectious Disease issue of Today's Clinical Lab

Reimagining Immunoassay Testing: The Case for Dry Reagent Systems

Today's Clinical Lab, Tosoh Bioscience

Explore how dry reagent immunoassays can reduce waste, simplify workflows, and support high-throughput lab efficiency without compromising accuracy

Urine specimens constitute a significant portion of the laboratory's daily workload, yet key preanalytical steps like aliquoting are often still performed manually.

New Automated System Transforms Urine Specimen Processing in Clinical Labs

Copan Diagnostics

Unveiled at ADLM 2025, Copan's UriVerse™ streamlines preanalytical steps like aliquoting, labeling, and capping to boost lab efficiency and accuracy

MosaiQ AiPlex® Vasculitis assay, now available for clinical use in the European Union and other CE mark accepting countries.

New Multiplex Assay Aims to Accelerate Diagnosis of Autoimmune Vasculitis

AliveDx

A new CE-marked test for MPO, PR3, and anti-GBM autoantibodies offers faster, simplified serological evaluation and may help labs streamline workflows in vasculitis testing

First developed in the 1940s, PFAS, or per- and poly-fluoroalkyl substances, were designed to resist water, oil, grease, and heat, making them useful in numerous consumer products and across multiple industries.

Exposure to PFAS in Drinking Water Linked to Higher Blood Levels of These ‘Forever’ Chemicals

Association for Diagnostics and Laboratory Medicine

Leading study lays the foundation for addressing the public health threat of high blood levels of PFAS

These prestigious awards recognize the top-performing clinical laboratory equipment manufacturers based on real-world user satisfaction and system performance.

Top Lab Equipment Manufacturers Recognized at ADLM 2025

Today's Clinical Lab

Roche, bioMérieux, and QuidelOrtho earn top honors in chemistry, immunoassay, and integrated systems through IMV’s ServiceTrak™ Awards

Researchers have long known that standard urine drug screening can sometimes trigger false positives, or erroneous results that indicate the presence of a drug when there isn’t one.

Standard Drug Screening Fails to Identify Some Children Who Have Been Exposed to Substances in Unsafe Home Environments

Association for Diagnostics and Laboratory Medicine

The study highlights an adjustment that clinical labs can make to improve the accuracy of results

Each year, more than 475,000 Americans are diagnosed with Lyme disease—a number that is only expected to climb due to climate change expanding the range of areas where ticks can live.

Breaking Research at ADLM 2025: AI Poised to Revolutionize Lyme Disease Testing, Treatment

Association for Diagnostics and Laboratory Medicine

The findings spotlight the potential of AI to make a profound, positive difference in people’s lives

“The ADLM 2025 program spotlights the sweeping scope of laboratory medicine in solving the most pressing problems of our time,” said ADLM CEO Mark J. Golden.

ADLM 2025 to Address Medical Misinformation, Health Risks Posed by Plastics, AI Integration into Care, Precision Medicine, and More

Association for Diagnostics and Laboratory Medicine

This year’s meeting, in partnership with CSCC, explores clinical AI, medical misinformation, plastics in health, and advances in genomics and microbiome medicine

With an eye toward improving care, researchers have developed new automated lab procedures for detecting opioids in tiny amounts of blood.

New Opioid Testing Techniques Could Lead to Better Therapies

Brown University

New diagnostic tools for detecting opioids in adults and infants could help health workers more effectively treat opioid-related conditions

Minimally invasive testing options can be less risky and less expensive compared to traditional, invasive biopsies

Deploying Minimally Invasive Transplant Tests in Kidney Disease Treatment

Tina Liedtky

Minimally invasive testing options can be less risky and less expensive compared to traditional, invasive biopsies

Greener Clinical Lab Testing Now Within Reach: New Solutions from Siemens Healthineers

Siemens Healthineers

The Atellica instruments from Siemens Healthineers are now My Green Lab ACT Ecolabel certified

Photo of a clinical research scientist wearing PPE in a laboratory and pipetting urine samples for testing in clinical trials inside of a fume hood.

Urine Test Could Halve Post-Operative CT Scans for Kidney Cancer

European Association of Urology

Results from the first cohort of the AURORAX 087A study show the new biomarker-based test provides a more robust basis for making decisions on treatment than scans alone